Liang J - Search Results

1

Different cellular localization of NF-κB p65 expression as an indicator of different prognoses of stage I-III gastric cancer patients.

Zhou F, Wei H, Ding A, Qiu W, Feng L, Zhou Q, Liang J, Yue L. Zhou F, et al. Among authors: liang j. Clin Transl Sci. 2013 Oct;6(5):381-5. doi: 10.1111/cts.12065. Epub 2013 May 8. Clin Transl Sci. 2013. PMID: 24127926 Free PMC article.

2

Genetic polymorphism of GSTP1: prediction of clinical outcome to oxaliplatin/5-FU-based chemotherapy in advanced gastric cancer.

Li QF, Yao RY, Liu KW, Lv HY, Jiang T, Liang J. Li QF, et al. Among authors: liang j. J Korean Med Sci. 2010 Jun;25(6):846-52. doi: 10.3346/jkms.2010.25.6.846. Epub 2010 May 24. J Korean Med Sci. 2010. PMID: 20514304 Free PMC article.

3

[Association between genetic polymorphisms of ERCC1, XRCC1, GSTP1 and survival of advanced gastric cancer patients treated with oxaliplatin/5-Fu-based chemotherapy].

Liang J, Li QF, Yao RY, Lü HY, Jiang J, Sun YY, Song SA, Jiang T. Liang J, et al. Zhonghua Zhong Liu Za Zhi. 2010 Jul;32(7):515-9. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 21029695 Chinese.

4

Anti-tumor effects of pEgr-1-endostatin-TNF-α recombinant plasmid expression induced by ionizing radiation.

Zhang Y, Qiu W, Liang J, Yu Z, Yue L. Zhang Y, et al. Among authors: liang j. Asian Pac J Cancer Prev. 2011;12(11):2933-7. Asian Pac J Cancer Prev. 2011. PMID: 22393966 Free article.

5

Genetic polymorphism of XRCC1 correlated with response to oxaliplatin-based chemotherapy in advanced colorectal cancer.

Lv H, Li Q, Qiu W, Xiang J, Wei H, Liang H, Sui A, Liang J. Lv H, et al. Among authors: liang h, liang j. Pathol Oncol Res. 2012 Oct;18(4):1009-14. doi: 10.1007/s12253-012-9536-6. Epub 2012 May 2. Pathol Oncol Res. 2012. PMID: 22549274 Free article. Clinical Trial.

6

Inhibition of hepatocellular carcinoma cell growth by an anti-insulin-like growth factor-I receptor monoclonal antibody.

Yue L, Wang Y, Wang H, Gao H, Liang J, Sui A, Xiang J, Zhou F, Xu C, Zhao W, Liang W, Yao R. Yue L, et al. Among authors: liang w, liang j. Oncol Rep. 2012 Oct;28(4):1453-60. doi: 10.3892/or.2012.1960. Epub 2012 Aug 8. Oncol Rep. 2012. PMID: 22895605

7

Genetic polymorphism of XRCC1 correlated with response to oxaliplatin-based chemotherapy in advanced colorectal cancer.

Lv H, Li Q, Qiu W, Xiang J, Wei H, Liang H, Sui A, Liang J. Lv H, et al. Among authors: liang h, liang j. Cancer Invest. 2013 Jan;31(1):24-8. doi: 10.3109/07357907.2012.716468. Cancer Invest. 2013. Retraction in: Cancer Invest. 2013 Dec;31(10):661. doi: 10.3109/07357907.2013.854525 PMID: 23327191 Retracted. Clinical Trial.

8

Clinicopathological significance of S100A4 expression in human hepatocellular carcinoma.

Liu Z, Liu H, Pan H, Du Q, Liang J. Liu Z, et al. Among authors: liang j. J Int Med Res. 2013 Apr;41(2):457-62. doi: 10.1177/0300060513478086. J Int Med Res. 2013. PMID: 23781010 Free article.

9

Forkhead box transcription factor 1 expression in gastric cancer: FOXM1 is a poor prognostic factor and mediates resistance to docetaxel.

Li X, Qiu W, Liu B, Yao R, Liu S, Yao Y, Liang J. Li X, et al. Among authors: liang j. J Transl Med. 2013 Sep 3;11:204. doi: 10.1186/1479-5876-11-204. J Transl Med. 2013. PMID: 24004449 Free PMC article.

10

Clinical significance and positive correlation of FoxM1 and Her-2 expression in gastric cancer.

Li X, Tang D, Yao Y, Qi W, Liang J. Li X, et al. Among authors: liang j. Clin Exp Med. 2014 Nov;14(4):447-55. doi: 10.1007/s10238-013-0261-6. Epub 2013 Oct 8. Clin Exp Med. 2014. PMID: 24101296

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18,277 results

Search Page

Filters